Madison Elsaadi
Stock Analyst at B. Riley Securities
(4.83)
# 409
Out of 4,355 analysts
49
Total ratings
69.2%
Success rate
67.1%
Average return
Main Sectors:
Stocks Rated by Madison Elsaadi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ETON Eton Pharmaceuticals | Maintained: Buy | $31 → $40 | $30.45 | +31.36% | 13 | May 15, 2026 | |
| IRD Opus Genetics | Maintained: Buy | $9 → $10 | $4.36 | +129.36% | 2 | Apr 30, 2026 | |
| WVE Wave Life Sciences | Rated: Buy | $37 → $31 | $6.58 | +371.12% | 14 | Apr 30, 2026 | |
| CMPS COMPASS Pathways | Initiated Coverage: Buy | $17 | $13.06 | +30.17% | 1 | Apr 24, 2026 | |
| CAPR Capricor Therapeutics | Rated: Buy | $50 → $63 | $29.96 | +110.28% | 6 | Mar 13, 2026 | |
| OVID Ovid Therapeutics | Reiterated: Buy | $5 | $2.73 | +83.15% | 3 | Mar 10, 2026 | |
| VNDA Vanda Pharmaceuticals | Maintained: Buy | $14 → $17 | $6.45 | +163.57% | 4 | Feb 25, 2026 | |
| TSX: FRX Fennec Pharmaceuticals Inc. | Initiated Coverage: Buy | $22.08 | $13.67 | +61.54% | 1 | Feb 12, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Maintained: Buy | $61 → $101 | $77.91 | +29.64% | 4 | Jan 22, 2026 | |
| AXSM Axsome Therapeutics | Initiated Coverage: Buy | $179 | $234.48 | -23.66% | 1 | Oct 1, 2025 |
Eton Pharmaceuticals
May 15, 2026
Maintained: Buy
Price Target: $31 → $40
Current: $30.45
Upside: +31.36%
Opus Genetics
Apr 30, 2026
Maintained: Buy
Price Target: $9 → $10
Current: $4.36
Upside: +129.36%
Wave Life Sciences
Apr 30, 2026
Rated: Buy
Price Target: $37 → $31
Current: $6.58
Upside: +371.12%
COMPASS Pathways
Apr 24, 2026
Initiated Coverage: Buy
Price Target: $17
Current: $13.06
Upside: +30.17%
Capricor Therapeutics
Mar 13, 2026
Rated: Buy
Price Target: $50 → $63
Current: $29.96
Upside: +110.28%
Ovid Therapeutics
Mar 10, 2026
Reiterated: Buy
Price Target: $5
Current: $2.73
Upside: +83.15%
Vanda Pharmaceuticals
Feb 25, 2026
Maintained: Buy
Price Target: $14 → $17
Current: $6.45
Upside: +163.57%
Fennec Pharmaceuticals Inc.
Feb 12, 2026
Initiated Coverage: Buy
Price Target: $22.08
Current: $13.67
Upside: +61.54%
Arrowhead Pharmaceuticals
Jan 22, 2026
Maintained: Buy
Price Target: $61 → $101
Current: $77.91
Upside: +29.64%
Axsome Therapeutics
Oct 1, 2025
Initiated Coverage: Buy
Price Target: $179
Current: $234.48
Upside: -23.66%